Skip to main content
. 2019 Jul 16;10:695. doi: 10.3389/fneur.2019.00695

Table 3.

Outcomes measures of the open label phase.

Outcomes FR (n = 27) CW (n = 27) p-value
ANNUAL RELAPSE RATE
Mean ± SD 0.20 ± 0.21 0.40 ± 0.73 0.276a
Median (IQR) 0.14 (0–0.37) 0.25 (0–0.50)
Range 0–0.7 0–3.5
EDSS SCORE
Mean ± SD 2.42 ± 2.14 2.40 ± 2.29 0.691a
Median (IQR) 1.5 (1–3.5) 1.5 (1–3.5)
Range 0–7 0–7
SHIFTING TO A PROGRESSIVE DISEASE
N (%) 4 (0.14) 5 (0.18) 0.715b
a

Non-parametric Wilcoxon rank-sum test (for variables with non-normal distribution).

b

Chi-square test for categorical variables.